I blatantly copied the headline from the WSJ article. You need a subscription to read more than a few paragraphs of the article. But do you really need to read anything more than the headline to understand the story?
I am Shocked! Shocked! that pharma is trying to shut down a competing way to improve smokers’ health that competes with their ineffective products. Of course, we should expect as much from them; they do not pretend to be public health advocates like the anti-tobacco extremists, the ones who will fight Glaxo’s battle to shut down the novel low-risk products for them.
– Carl V. Phillips